Back to top
more

Cassava Sciences (SAVA)

(Delayed Data from NSDQ)

$12.35 USD

12.35
17,777,856

-6.60 (-34.83%)

Updated Jun 28, 2024 04:00 PM ET

After-Market: $13.36 +1.01 (8.18%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.08%
2Buy17.91%
3Hold9.44%
4Sell5.10%
5Strong Sell2.55%
S&P50011.04%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value F Growth A Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 40% (99 out of 249)

Industry: Medical - Drugs

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Brokerage Reports

1 item in cart

View Cart/Checkout

Cassava Sciences, Inc. [SAVA]

Reports for Purchase

Showing records 81 - 100 ( 125 total )

Company: Cassava Sciences, Inc.

Industry: Medical - Drugs

Record: 81

07/11/2022

Company Report

Pages: 15

Optimized Entry and Exit Levels for SAVA 71122

Provider: Stock Traders Daily

Analyst: Research Department

Price: 25.00

Research Provided by a Third Party

Company: Cassava Sciences, Inc.

Industry: Medical - Drugs

Record: 82

07/01/2022

Company Report

Pages: 18

Optimized Entry and Exit Levels for SAVA 7122

Provider: Stock Traders Daily

Analyst: Research Department

Price: 25.00

Research Provided by a Third Party

Company: Cassava Sciences, Inc.

Industry: Medical - Drugs

Record: 83

06/21/2022

Company Report

Pages: 16

Optimized Entry and Exit Levels for SAVA 62122

Provider: Stock Traders Daily

Analyst: Research Department

Price: 25.00

Research Provided by a Third Party

Company: Cassava Sciences, Inc.

Industry: Medical - Drugs

Record: 84

06/11/2022

Company Report

Pages: 16

Optimized Entry and Exit Levels for SAVA 61122

Provider: Stock Traders Daily

Analyst: Research Department

Price: 25.00

Research Provided by a Third Party

Company: Cassava Sciences, Inc.

Industry: Medical - Drugs

Record: 85

06/02/2022

Company Report

Pages: 8

Another of Cassava?s Roots Has Been Pulled: Maintain SELL: $8 Price Target

Provider: Univest Securities, LLC

Analyst: Research Department

Price: 12.50

Research Provided by a Third Party

Company: Cassava Sciences, Inc.

Industry: Medical - Drugs

Record: 86

06/01/2022

Company Report

Pages: 16

Optimized Entry and Exit Levels for SAVA 6122

Provider: Stock Traders Daily

Analyst: Research Department

Price: 25.00

Research Provided by a Third Party

Company: Cassava Sciences, Inc.

Industry: Medical - Drugs

Record: 87

05/11/2022

Company Report

Pages: 17

Comprehensive Technical and Fundamental Analysis for SAVA.

Provider: Stock Traders Daily

Analyst: Research Department

Price: 25.00

Research Provided by a Third Party

Company: Cassava Sciences, Inc.

Industry: Medical - Drugs

Record: 88

05/06/2022

Company Report

Pages: 8

Phase 3 Enrollment Lagging; At Current Pace Could Take ~8 Years: Maintain Sell, $8 PT

Provider: Univest Securities, LLC

Analyst: Research Department

Price: 12.50

Research Provided by a Third Party

Company: Cassava Sciences, Inc.

Industry: Medical - Drugs

Record: 89

05/05/2022

Company Report

Pages: 4

Momentum Regained With Uptick in Phase 3 Enrollment; Reiterate Buy and $124 PT

Provider: H.C. Wainwright & Co., Inc.

Analyst: BERNARDINO V

Price: 5.00

Research Provided by a Third Party

Company: Cassava Sciences, Inc.

Industry: Medical - Drugs

Record: 90

04/27/2022

Company Report

Pages: 8

SavaDx: Antibody or No Antibody, Unclear; Maintain SELL, $8 Price Target

Provider: Univest Securities, LLC

Analyst: Research Department

Price: 12.50

Research Provided by a Third Party

Company: Cassava Sciences, Inc.

Industry: Medical - Drugs

Record: 91

04/21/2022

Company Report

Pages: 16

Comprehensive Technical and Fundamental Analysis for SAVA.

Provider: Stock Traders Daily

Analyst: Research Department

Price: 25.00

Research Provided by a Third Party

Company: Cassava Sciences, Inc.

Industry: Medical - Drugs

Record: 92

04/11/2022

Company Report

Pages: 16

Comprehensive Technical and Fundamental Analysis for SAVA.

Provider: Stock Traders Daily

Analyst: Research Department

Price: 25.00

Research Provided by a Third Party

Company: Cassava Sciences, Inc.

Industry: Medical - Drugs

Record: 93

04/05/2022

Company Report

Pages: 8

Cassava?s Roots are Being Investigated: Maintain SELL, $8 Price Target

Provider: Univest Securities, LLC

Analyst: Research Department

Price: 12.50

Research Provided by a Third Party

Company: Cassava Sciences, Inc.

Industry: Medical - Drugs

Record: 94

04/01/2022

Company Report

Pages: 24

This Cassava Won?t Take Root: Initiating Coverage of SAVA with a SELL, $8 Price Target

Provider: Univest Securities, LLC

Analyst: Research Department

Price: 35.00

Research Provided by a Third Party

Company: Cassava Sciences, Inc.

Industry: Medical - Drugs

Record: 95

04/01/2022

Company Report

Pages: 16

Comprehensive Technical and Fundamental Analysis for SAVA.

Provider: Stock Traders Daily

Analyst: Research Department

Price: 25.00

Research Provided by a Third Party

Company: Cassava Sciences, Inc.

Industry: Medical - Drugs

Record: 96

03/01/2022

Company Report

Pages: 5

Showing It Can Do Big Things; Two Large Phase 3 Trials Initiated in 2021; Reiterate Buy and $124 PT

Provider: H.C. Wainwright & Co., Inc.

Analyst: BERNARDINO V

Price: 5.00

Research Provided by a Third Party

Company: Cassava Sciences, Inc.

Industry: Medical - Drugs

Record: 97

03/01/2022

Company Report

Pages: 24

Comprehensive Technical and Fundamental Analysis for SAVA.

Provider: Stock Traders Daily

Analyst: Research Department

Price: 35.00

Research Provided by a Third Party

Company: Cassava Sciences, Inc.

Industry: Medical - Drugs

Record: 98

02/21/2022

Company Report

Pages: 24

Comprehensive Technical and Fundamental Analysis for SAVA.

Provider: Stock Traders Daily

Analyst: Research Department

Price: 35.00

Research Provided by a Third Party

Company: Cassava Sciences, Inc.

Industry: Medical - Drugs

Record: 99

02/11/2022

Company Report

Pages: 24

Comprehensive Technical and Fundamental Analysis for SAVA.

Provider: Stock Traders Daily

Analyst: Research Department

Price: 35.00

Research Provided by a Third Party

Company: Cassava Sciences, Inc.

Industry: Medical - Drugs

Record: 100

02/01/2022

Company Report

Pages: 24

Comprehensive Technical and Fundamental Analysis for SAVA.

Provider: Stock Traders Daily

Analyst: Research Department

Price: 35.00

Research Provided by a Third Party